Johnson & Johnson JNJ
NYSE JNJ
$269.99 -0.22 (-0.08%)
At close: Sep 18, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Preferred Shares (2019)

Johnson & Johnson's (JNJ) quarterly Preferred Shares came in at $2.0 million in Q4 2019.

Analysis

Johnson & Johnson (JNJ) Preferred Shares (2019) Analysis & Trends

Johnson & Johnson has disclosed Preferred Shares across 1 years of filings, most recently posting $2.0 million for Q4 2019.

  • In Q4 2019, Preferred Shares changed N/A year-over-year to $2.0 million; the TTM figure through Dec 2019 stood at $2.0 million (changed N/A YoY), while the FY2021 annual figure was $2.0 million, changed 0.0% from the prior year.
  • Preferred Shares came in at $2.0 million for Q4 2019 at Johnson & Johnson.
  • In the past five years, Preferred Shares ranged from a high of $2.0 million in Q4 2019 to a low of $2.0 million in Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 29, 2019 2.00 Mn